Provides Information on SynDB, an Online Database of Synapse Related Proteins

New York, NY -- (SBWire) -- 07/19/2013, a website dedicated to the field of synapse proteomics, has recently launched itself and has already published extensive information on the popular online database SynDB. An essential tool for study of synapse proteomics, SynDB is a collection of over 13580 unique proteins spanning 650 species and 264 domain families. Synapse proteome and phosphoproteome fields have seen a major leap in the past few years and their use by drug companies has been on an all time high.

SynDB specifically contains list of all proteins known or predicted to be related to synapse or synaptic activity. It is the largest online resource which is also regularly updated according to any research of new synapse related proteins. The synaptic database is also coupled with Synapse Ontology (SynO), which is another very useful feature to describe synaptic structures and functions.

Leading drug companies have created popular products composed of proteins that affect the synapse. Many of these products are widely used despite the harmful side effects they present. Another initiative has been taken up by to guide the general public in using those products that are safe and effective. The company is currently focused on reviewing and researching Canadian pharmacy online drug providers. A ranking of the most reliable, safe and yet effective drugs from numerous online pharmacies has now been published by the company.

One such drug that works by affecting the brain synapse is the popular Chantix (Varenicline) tablets, consumed to help smokers quit. With over 44% success rate, Chantix is considered as one of the most effective ways to quit smoking and as one of the successful drugs of synapse proteomics. Many smokers buy Chantix to get rid of their unhealthy habit and see results within the 9-12 weeks duration. Chantix focuses on eliminating the urge of smoking by targeting the nicotine receptors in the brain, attaching to them and eventually blocking nicotine from reaching them. Hence, consumers of Chantix automatically quit smoking regardless of whether they continue smoking while consumption or not.

About Salimem SynDB
Salimem SynDB is one of the leading companies that provides information on Proteomics, large scale study of proteins specifically Synapse Proteomics. Currently they are focused on the online protein database SynDB which is a comprehensive collection of proteins with over 13580 unique proteins spanning 650 species and 264 domain families. Through the online platform,, extensive information on SynDB can be viewed. Salimem SynDB is known for providing free and useful knowledge on synapse proteomics.

For more information about SynDB, or to schedule a meeting or interview with founders of, please call at 888.198.9461 or email to

Media Relations Contact

Irmind Salimem

View this press release online at: